常茂生物化学工程股份有限公司于2026年2月2日发布2026年1月股份变动月报表，报告期覆盖截至2026年1月31日的股本变动情况。公告显示，公司在本月内未有新增发行、购回或注销股份，股本结构维持不变。
公司现有普通股包括H股、内资股及外资股三类。H股于香港联交所上市，数量为183,700,000股，面值人民币0.1元；内资股数量为2,500,000股，面值人民币0.1元；外资股数量为343,500,000股，面值人民币0.1元。截至1月底，公司法定注册股本总额为人民币52,970,000元。
月报表同时确认当月无任何股份期权、股权激励计划，以及无任何购回及注销活动。公司声明已遵照香港联交所《上市规则》及相关法律法规办理所有证券发行或转让事宜。公告由公司秘书温珮玲呈交。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.